Applying Shared Decision-Making in Cancer Treatment and Management to Optimize Multidisciplinary Care: A Docuseries on Cutaneous Malignancies: Cutaneous Squamous Cell Carcinoma (cSCC)
Released On
March 6, 2024
Expires On
March 6, 2025
Media Type
Internet
Completion Time
30 minutes
Specialty
Cutaneous Malignancies; Cutaneous Squamous Cell Carcinoma (cSCC), Dermatology, Hematology-Oncology, Surgery
Topic(s)
Cutaneous Malignancies: Cutaneous Squamous Cell Carcinoma (cSCC)
This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc..
Credit Available
- Physicians — maximum of 0.5 AMA PRA Category 1 Credits™
- Nurses — maximum of 0.5 ANCC contact hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This program will reach the medical oncology team, including dermatologists, oncologists, and other healthcare professionals working collaboratively to provide the best possible care for patients with cutaneous malignancies.
Program Overview
This enduring activity uses a unique documentary approach to share the patient experience of diagnosis and treatment of cutaneous squamous cell carcinoma (cSCC). It highlights their experiences with surgery, radiation, chemotherapy, and immunotherapy with commentary from our faculty expert. The goal is to help learners identify potential immune targets and systemic treatment strategies; optimize multidisciplinary management; and incorporate shared decision making in arriving at individualized care for their patients with cSCC.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Implement best practices for assessment of targetable mutations and eligibility for immuno-therapeutic treatment of cutaneous malignancies
- Integrate best practices for patient education and communication, including strategies for discussing treatment options, concerns and monitoring for/managing adverse events
Faculty
Program Chair and Faculty
Emily S. Ruiz, MD, MPH
Associate Professor of Dermatology
Harvard Medical School
Director, High-Risk Skin Cancer Clinic
Dana-Farber Cancer Institute
Program Director, Micrographic Surgery and Dermatology Oncology Fellowship
Brigham and Women’s Hospital
Boston, MA
Featuring
Robert Lambert
Tewksbury, MA
Joint Accreditation Statement
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit Designation
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nurses (ANCC) Credit Designation
Med Learning Group designates this activity for a maximum of 0.5 ANCC contact hours.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure of Relevant Financial Relationships
- Emily S. Ruiz, MD
- Consulting Fees: Checkpoint Therapeutics, Regeneron Pharmaceuticals, and Feldman Pharmaceuticals.
- Principal investigator: Regeneron Pharmaceuticals
- Co-investigator : Regeneron Pharmaceuticals, Merck and Castle Biosciences
Robert Lambert has nothing to disclose.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Nicole Longo, DO, FACOI, VP of Med/Sci Services & Learner Engagement for Med Learning Group has nothing to disclose.
Debra Gordon, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
Lauren Bartunek, Senior Program Manager for Med Learning Group, has nothing to disclose.
Heather Gee, Program Coordinator for Med Learning Group, has nothing to disclose.
Michael Milano, MD, PhD, discloses that he receives UpToDate author royalties from Wolters Kluwer.
Joan Duer-Hefele, RN, MA, CCRC, has nothing to disclose.
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Method of Participation
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclaimer
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: https://www.medlearninggroup.com/privacy-policy/
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Content - Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.